Print

The Leading Group on Innovative Financing for Development 2010 Report to the Taskforce

on .

Globalizing Solidarity: The Case for Financial Levies

"Innovative financing mechanisms have demonstrated their potential for securing additional resources for distribution to low-income countries. The success of the air ticket solidarity levy, as well as the governing body of revenue (UNITAID, International Drug Purchase Facility) has shown it is possible to meet long-term needs through non-traditional financing mechanisms."

Read the full report here, or visit the website: http://www.leadinggroup.org/article668.html.

Print

WHO Note on the potential stock-out of paediatric ddI

on .

The HIV/AIDS Department of WHO has issued a note to National AIDS Programmes, procurement agents, and stakeholders on the potential stock-out of paediatric ddl 25mg and 50mg buffered tablets. In the note, WHO recommends a series of short-term actions to minimize the impact of a potential stock-out of paediatric ddl 25mg and 50mg. In addition, a number of longer-term actions are also recommended with the aim of rationalizing the use of ddl products in children in line with the new WHO normative guidance on the use of ARVs in second-line therapy.
Print

Additional contribution from France for 2009

on .

The French Government has recently announced that their contribution to UNITAID for 2009 has been increased by an additional 31.5 million Euros.

The total French contribution for 2009 is then 141.5 million Euros.

Thank You to France.

Print

MORE COUNTRIES SHOULD APPLY SOLIDARITY AIR LEVY TO COMPLEMENT FUNDING FOR GLOBAL HEALTH

on .

SECURE FUNDING KEY TO KEEP EXPANDING TREATMENT FOR PEOPLE WITH AIDS, MALARIA AND TB 

Geneva, 10 June 2010 At a meeting which ended last night, the Executive Board of UNITAID approved a plan to step up efforts to enlist more countries to apply a solidarity levy on air tickets to provide additional funding for the health Millennium Development Goals. The Board approved a number of resolutions, among them the final phase of the establishment of a medicines patent pool, but a situation of depleting funds raises concerns for the many patients currently being treated by UNITAID.

Print

UNITAID Response to Bristol Myers Squibb Interrupted Production of HIV Medicines for Infants

on .

Geneva 7 June 2010 UNITAID is deeply concerned that the provision of a key paediatric AIDS medicine produced by Bristol Myers Squibb will be interrupted in June 2010 until at least April 2011. The medicine, didanosine 25 mg and 50 mg, is supplied by UNITAID through the Clinton Health Access Initiative (CHAI) to between 4,000-7,000 infants in 40 countries. Interruption of treatment would seriously jeopardize these young children's survival.

Print

EU Commission calls Member States to get back on track for MDGs and more and better aid

on .

22 April 2010 - Today, the European Commission has adopted an ambitious action plan for EU action to speed up progress towards the Millennium Development Goals (MDGs). In 2009, the EU aid level has slightly decreased and amounted 49bn. This corresponds to 0.42% of EU GNI, making the EU still far from meeting the intermediate collective target of 0,56% GNI by 2010, before reaching 0.7% EU GNI by 2015.

Print

Patent Pool budget approved - implementation begins

on .

The UNITAID Finance and Administration Board Committee this week approved a 2010 budget of US$ 4 million towards the establishment of the Medicines Patent Pool Foundation, a voluntary licensing mechanism that will allow for patent holders of antiretroviral medicines to license their patents to generic manufacturers. UNITAID is now in the process of finalising a memorandum of understanding to be entered into as soon as the Patent Pool Foundation is established in June.

Grantees

  • partners-EN-1
  • partners-EN-2
  • partners-EN-3